Mark Ramaekers
Papers
1
Total Citations
26
H-Index
1
About
Mark Ramaekers is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex hepatopancreatobiliary (HPB) malignancies. His major contributions center on comparing the safety, efficacy, and oncological outcomes of laparoscopic, robotic, and open pancreatoduodenectomy—one of the most challenging abdominal surgeries. In his highly cited 2022 study, Ramaekers demonstrated that minimally invasive pancreatoduodenectomy (MIPD) offers comparable long-term outcomes to open surgery for distal cholangiocarcinoma, a critical finding that supports the broader adoption of these less invasive approaches. With over 26 citations already, this work has significantly influenced clinical decision-making and surgical training. Ramaekers’ research is notable for its rigorous methodology and focus on patient-centered outcomes, including survival and recovery. His achievements include advancing the evidence base for robotic and laparoscopic HPB surgery, helping to define best practices for treating complex biliary tract cancers. For students and researchers, Ramaekers exemplifies how comparative effectiveness research can directly shape modern surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1